Determination of the Predictive Factors in the Reversibility or the Aggravation in the Disorders of the Glucose Metabolism in Cystic Fibrosis Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

230 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-04-30

Study Completion Date

2014-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For some years, the investigators observe an increase of the arisen of diabetes in cystic fibrosis patients However, this diabetes may be reversible. The investigators speak about " Cystic fibrosis related diabetes.". The objective of this project, is to know better what facilitates the appearance and the reversibility of the diabetes, such as the genetic mutations, the respiratory state and the lung infections. Theses knowledges should allow to adapt the screening of diabetes, and its treatment, for the patients affected by cystic fibrosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predisposition Genes in Monogenic Diabetes (DIAMONO)

NCT02634229

Non Autoimmune Monogenic Diabetes

COMPLETED

Study of Diabetes' Risk Factors and Accelerated Aging According to Socio-economic Status in a Population From the North of France

NCT05717491

Diabetes PreDiabetes

COMPLETED

A Study on Predictive Model for New-onset Diabetic Foot in Type 2 Diabetes Patients.

NCT05519163

Diabetic Foot

COMPLETED

Extreme Phenotypes to Identify Susceptibility of Patients Living With Type 2 to Diabetes Related Complications

NCT07250607

Diabete Type 2 Diabetes Complications

ACTIVE_NOT_RECRUITING

Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes

NCT04550403

Diabetes Mellitus Covid19

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes in Cystic Fibrosis Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prospective cohort with an annual follow-up

Annualfollow-up including :

* oral glucose tolerance test
* dietary survey
* biological evaluation
* bacteriological and respiratory measures
* dual-energy x-ray absorptiometry
* physical activity survey

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cystic fibrosis patients with at least one visit in Cystic fibrosis Center in Rhône-Alpes (France) during the second half-year 2008
* Patients with disorders or not of the glucose metabolism
* Patient with pancreatic insufficiency